Arkayli Biopharma Receives FDA SMP, SBIR Grant
Arkayli Biopharma, a biopharmaceutical company developing innovative therapies for rare dermatologic conditions, announced today that it has received a Study May Proceed (SMP) letter from the U.S. Food and Drug…
